WinHealth Pharma

Explore the latest insights on WinHealth Pharma and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of WinHealth Pharma’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Company Drug

Amgen’s Dazodalibep Hits Phase 3 Milestone in OASIZ‑301 – First Trial to Show Clinically Meaningful Improvement in Systemic Sjögren’s Disease Activity

Amgen (NASDAQ: AMGN) announced results from the Phase 3 OASIZ‑301 study of dazodalibep, a potential first‑in‑class CD40L antagonist fusion protein, which Amgen describes as the only global Phase 3 trial…

November 12, 2026

FDA Flags Potential NAION Vision‑Loss Risk with GLP‑1 RA Medications – Labeling Update Required Across the Drug Class

November 12, 2026

Pfizer and Blackstone Life Sciences Strike USD 1.5 Billion Co‑Funding Deal for Berobenatide – Potential First‑in‑Class Monthly GLP‑1 for Obesity

November 12, 2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.

Explore Now

Company Drug